Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 61

1.

[STUDYING SOME PHARMACOLOGICAL EFFECTS OF NEW 3-HYDROXYPYRIDINE DERIVATIVE].

Yasnetsov VV, Tsublova EG, Yasnetsov VV, Skachilova SY, Karsanova SK, Ivanov YV.

Eksp Klin Farmakol. 2016;79(2):3-8. Russian.

PMID:
27416675
2.

[Optimization of pharmacological therapy for weakness syndrome in incurable patients].

Ryazankina AA, Rozengard SA, Glushchenko VA, Karitsky AP, Kvashnin AV.

Vopr Onkol. 2015;61(2):270-3. Russian.

PMID:
26087610
3.

Ruthenium-catalyzed reductive amination without an external hydrogen source.

Kolesnikov PN, Yagafarov NZ, Usanov DL, Maleev VI, Chusov D.

Org Lett. 2015 Jan 16;17(2):173-5. doi: 10.1021/ol503595m. Epub 2014 Dec 31.

PMID:
25549756
4.
5.

Correcting effect of ladasten on variations in the subpopulation composition of T lymphocytes in C57BL/6 mice on the experimental model of an anxious-depressive state.

Tallerova AV, Kovalenko LP, Kuznetsova OS, Durnev AD, Seredenin SB.

Bull Exp Biol Med. 2014 Jan;156(3):335-7. doi: 10.1007/s10517-014-2343-1. Epub 2014 Jan 16.

PMID:
24771370
6.

The pharmacology of actoprotectors: practical application for improvement of mental and physical performance.

Oliynyk S, Oh S.

Biomol Ther (Seoul). 2012 Sep;20(5):446-56. doi: 10.4062/biomolther.2012.20.5.446. Review.

7.

[Ladasten versus placebo effect self-evaluated by neurasthenia patients with different EEG alpha rhythm types].

Neznamov GG, Bochkarev VK, Reutova MA, Shabanova AA, Siuniakov SA.

Eksp Klin Farmakol. 2012;75(5):7-13. Russian.

PMID:
22834121
8.

Mechanisms of action of ladasten: activation of gene expression for neurotrophins and mitogen-activated kinases.

Salimgareeva MKh, Yamidanov RS, Vakhitova YV, Seredenin SB.

Bull Exp Biol Med. 2012 Jan;152(3):313-7.

PMID:
22803074
9.

Effect of ladasten on the content of cytokine markers of inflammation and behavior of mice with experimental depression-like syndrome.

Tallerova AV, Kovalenko LP, Durnev AD, Seredenin SB.

Bull Exp Biol Med. 2011 Nov;152(1):58-60. English, Russian.

PMID:
22803040
10.

[Effect of ladasten on antenatal and postnatal development].

Bugaeva LI, Denisova TD, Spasov AA.

Eksp Klin Farmakol. 2012;75(4):23-5. Russian.

PMID:
22702107
11.

[Self-evaluation of single test doses and objective indices of ladasten vs. placebo efficacy in neurasthenic patients].

Reutova MA, Siuniakov SA, Siuniakov TS, Dorofeeva OA, Mametova LÉ, Neznamov GG.

Eksp Klin Farmakol. 2011;74(11):6-13. Russian.

PMID:
22288153
12.

[Effect of antiasthenic drug ladasten on the level of cytokines and behavior in experimental model of anxious depression in C57BL/6 male mice].

Tallerova AV, Kovalenko LP, Durnev AD, Seredenin SB.

Eksp Klin Farmakol. 2011;74(11):3-5. Russian.

PMID:
22288152
13.

Time course of histone deacetylase 1 and acetylated H3 and H4 histones in the brain of rats treated with ladasten.

Salimgareeva MKh, Sadovnikov SV, Yamidanov RS, Vakhitova YV, Seredenin SB.

Bull Exp Biol Med. 2011 Mar;150(5):603-6.

PMID:
22235395
15.

[Ladasten in the management of non-motor symptoms of Parkinson's disease].

Sarycheva TN, Rybak VA, Kurushina OV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(1):85-7. Russian. No abstract available.

PMID:
21434470
16.

[Treatment of asthenic disorders in patients with psychoautonomic syndrome: results of a multicenter study on efficacy and safety of ladasten].

Voznesenskaia TG, Fokina NM, Iakhno NN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2010;110(5 Pt 1):17-26. Russian.

PMID:
21322821
17.

Proteomic analysis and identification of ladasten target proteins in rat brain.

Yamidanov RS, Salimgareeva MKh, Sadovnikov SV, Vakhitova YV, Govorun VM, Seredenin SB.

Bull Exp Biol Med. 2010 Nov;149(6):775-8.

PMID:
21165444
18.

[Treatment of asthenic disorders in patients with psychoautonomic syndrome: results of a multicenter study on efficacy and safety of ladasten].

[No authors listed]

Zh Nevrol Psikhiatr Im S S Korsakova. 2010;110(5 Suppl 1):17-26. Russian.

PMID:
20559263
20.

[Role of the brain dopaminergic and serotoninergic systems in psychopharmacological effects of ladasten and sydnocarb].

Zimin IA, Abaimov DA, Budygin EA, Zolotarev IuA, Kovalev GI.

Eksp Klin Farmakol. 2010 Feb;73(2):2-5. Russian.

PMID:
20369592

Supplemental Content

Loading ...
Support Center